Skip to content

Effect of remifentanil induction on maternal, neonatal and placental transport undergoing cesarean section under general anesthesia

Effect of remifentanil induction on maternal, neonatal and placental transport undergoing cesarean section under general anesthesia

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046547
Enrollment
Unknown
Registered
2021-05-21
Start date
2021-05-26
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section under general anesthesia

Interventions

cesarean section under general anesthesia:Remifentanil Target concentration controlled intravenous injection

Sponsors

Chongqing Health Center for Women and Children
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. The puerpera who planned to undergo cesarean section under general anesthesia; 2. Aged over 18 years; 3. Have normal communication skills, be able to understand the content of informed consent and make independent judgment; 4. American Society of Anesthesiologists classification II-III; 5. Agreed to participate in this study and signed an informed consent.

Exclusion criteria

Exclusion criteria: 1. Women with high risk of difficult airway assessment or full stomach need conscious tracheal intubation; 2. With history of allergy to narcotic drugs.

Design outcomes

Primary

MeasureTime frame
Length of time between induction of anesthesia and delivery for fetuses: including induction of anesthesia - skin incision (I-S), induction of anesthesia - delivery (I-D), and incision of uterus - delivery (U-D);Plasma concentration of remifentanil, including MA, UV, UA, UV / MA;Newborn: Apgar score 1,5,10 min;Neonatal resuscitation;

Secondary

MeasureTime frame
Hemodynamic;Umbilical artery blood gas analysis;

Countries

China

Contacts

Public ContactYu Jin

Chongqing Health Center for Women and Children

dodoes@qq.com+86 18623117820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026